Stage-adjusted chemoradiation in cervical cancer after transperitoneal laparoscopic staging

Strahlentherapie und Onkologie

Volumn 183, Issue 9, 2007, Pages 473-478

  Marnitz, Simone ^a   Köhler, Christhardt ^a   Roth, Christina ^a   Füller, Jürgen ^b   Bischoff, Annett ^a   Wendt, Thomas ^b   Schneider, Achim ^a   Budach, Volker ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

Cervical cancer; Chemoradiation; Laparoscopic staging; Lymph node debulking; Toxicity; Upstaging

Indexed keywords

CARBOPLATIN; CISPLATIN; FLUOROURACIL; IFOSFAMIDE; RUBITECAN; TAXANE DERIVATIVE;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; CYTOREDUCTIVE SURGERY; FEMALE; HISTOLOGY; HUMAN; LAPAROSCOPIC SURGERY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MULTIPLE CYCLE TREATMENT; PROGNOSIS; SINGLE DRUG DOSE; UTERINE CERVIX CANCER;

ADENOCARCINOMA; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BRACHYTHERAPY; CARBOPLATIN; CARCINOMA, ADENOSQUAMOUS; CARCINOMA, SQUAMOUS CELL; CISPLATIN; COMBINED MODALITY THERAPY; DRUG ADMINISTRATION SCHEDULE; FEMALE; FLUOROURACIL; FOLLOW-UP STUDIES; HUMANS; LAPAROSCOPY; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; NEOPLASM INVASIVENESS; NEOPLASM STAGING; RADIOTHERAPY DOSAGE; RECTUM; SURVIVAL RATE; URINARY BLADDER; UTERINE CERVICAL NEOPLASMS;

EID: 34548301451     PISSN: 01797158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00066-007-1675-4     Document Type: Article

References (44)

1. Denschlag D, Gabriel B, Mueller-Lantzsch C, et al. Evaluation of patients after extraperitoneal lymph node dissection for cervical cancer. Gynecol Oncol 2005;96;658-64.
2. Downey GO, Potish RA, Adcock LL, et al. Pretreatment surgical staging in cervical carcinoma: therapeutic efficacy of pelvic lymph node resection. Am J Obstet Gynecol 1989;160:1055-61.
3. Dunst J, Haensgen G. Simultaneous radiochemotherapy in cervical cancer: recommendations for chemotherapy [Comment in: Strahlenther Onkol 2001;177:641-2; Reply to Comment in: Strahlenther Onkol 2001;177:634-3]. Strahlenther Onkol 2001;177:635-40.
4. Fyles A, Keane TJ, Barton M, et al. The effect of treatment duration and the local control of cervix cancer. Radiother Oncol 1992;25:273-9.
5. Goff BA, Muntz HG, Paley PJ, et al. Impact of surgical staging in women with locally advanced cervical cancer. Gynecol Oncol 1999;74:436-42.
6. Hacker NF, Wain GV, Nicklin JL. Resection of bulky positive lymph nodes in patients with cervical carcinoma. Int J Gynecol Cancer 1995;5:250-6.
7. Haensgen G, Dunst J. Statement in reply to the comment by Richard Pötter and Tomas Hendrik Knocke on: Dunst J, Haensgen G. Simultaneous radiochemotherapy in cervical cancer. Strahlenther Onkol 2001;177:634-4.
8. Hasenburg A, Salama JK, Van TJ, et al. Evaluation of patients after extraperitoneal lymph node dissection and subsequent radiotherapy for cervical cancer. Gynecol Oncol 2002;84:321-6.
9. Havrilevsky LJ, Kulasingam SL, Matchar DB, et al. FDG PET for management of cervical and ovarian cancer. Gynecol Oncol 2005;97:183-91.
10. Hertel H, Köhler C, Elhawary T, et al. Laparoscopic staging compared with imaging techniques in the staging of advanced cervical cancer. Gynecol Oncol 2002;87:46-51.
11. Keys HM, Bundy BN, Stehman FB, et al. Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma. N Engl J Med 1999;340:1154-61.
12. Kirwan JM, Symonds P, Green JA, et al. A systematic review of acute and late toxicity of concomitant chemoradiation for cervical cancer. Radiother Oncol 2003;68:217-26.
13. Köhler C, Klemm P, Schau A, et al. Introduction of transperitoneal lymphadenectomy in a gynecologic oncology center: analysis of 650 laparoscopic and/or paraaortic transperitoneal lymphadenectomies. Gynecol Oncol 2004;95:52-61.
14. Kupetz R, Thomas GM, Covens A. Is there a role for pelvic lymph node debulking in advanced cervical cancer? Gynecol Oncol 2002;87:163-70.
15. Lai CH, Huang KG, Hong JH, et al. Randomized trial of surgical (extraperitoneal or laparoscopic) versus clinical staging in locally advanced cervical cancer. Gynecol Oncol 2003;89:160-7.
16. Lanciano RM, Martz K, Coia LR, et al. Tumor and treatment factors improving outcome in stage III B cervix cancer. Int J Radiat Oncol Biol Phys 1991;20:95-100.
17. Marnitz S, Köhler C, Füller J, et al. Uterus necrosis after radiochemotherapy in two patients with advanced cervical cancer. Strahlenther Onkol 2006;182:45-51.
18. Marnitz S, Köhler C, Roth C, et al. Is there a benefit of pre treatment laparoscopic transperitoneal surgical staging in patients with advanced cervical cancer? Gynecol Oncol 2005;99:536-44.
19. Marnitz S, Köhler C, Schneider A, et al. Interindividual variability of lymph drainages in patients with cervical cancer. Implication on irradiation planning. Strahlenther Onkol 2006;185:80-5.
20. Morris M, Eifel PJ, Lu J. Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer. RTOG 90-01. N Engl J Med 1999;340:1137-43.
21. Narayan K, McKenzie AF, Hicks RJ, et al. Relation between FIGO stage, primary tumor volume, and presence of lymph node metastases in cervical cancer patients referred for radiotherapy. Int J Gynecol Cancer 2003;13:657-63.
22. Odunsi KO, Lele S, Ghamande S, et al. The impact of pre therapy extraperitoneal surgical staging on the evaluation and treatment of patients with locally advanced cervical cancer. Eur J Gynecol Oncol 2001;5:325-30.
23. Olofsen-van Acht MJ, Quint S, Seven M, et al. Three-dimensional treatment planning for postoperative radiotherapy in patients with node-positive cervical cancer. Comparison between a conventional and a conformal technique. Strahlenther Onkol 1999;175:462-9.
24. Peters WA 3rd, Liu PY, Barrett RJ 2nd, et al. Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix. J Clin Oncol 2000;18:1606-13.
25. Piver MS, Barlow JJ, Krishnamsetty R. Five-year survival (with no evidence of disease) in patients with biopsy-confirmed aortic node metastasis from cervical carcinoma. Am J Obstet Gynecol 1981;139:575-8.
26. Potish RA, Downey GO, Adcock LL, et al. The role of surgical debulking in cancer of the uterine cervix. Int J Radiat Oncol Biol Phys 1989;17:979-84.
27. Pötter R, Knocke TH. The potential of 3-D conformal brachytherapy and external beam radiotherapy in cervical cancer. [Comment on: Dunst J, Haensgen G. Simultaneous radiochemotherapy in cervical cancer. Strahlenther Onkol 2001;177:635-40.] Strahlenther Onkol 2001;177:641-2.
28. Querleu D, Dargent D, Ansquer Y. Extraperitoneal endosurgical aortic and common iliac dissection in the staging of bulky or advanced cervical carcinomas. Cancer 2000;88:1883-91.
29. Roh JW, Seo SS, Lee S, et al. Role of positron emission tomography in pretreatment lymph node staging of uterine cervical cancer: a prospective surgicopathologic correlation study. Eur J Cancer 2005;41:2086-92.
30. Rose PG, Bundy BN, Watkins EB, et al. Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. N Engl J Med 1999;340:1144-53.
31. Rotman M, Pajak TF, Choi K, et al. Prophylactic extended-field irradiation of para-aortic lymph nodes in stages IIb and bulky IIa cervical carcinomas. Ten years treatment result of RTOG 79-20. JAMA 1995;274:387-93.
32. Serkies K, Jassem J. Concurrent weekly cisplatin and radiotherapy in routine management of cervical cancer: a report on patient compliance and acute toxicity. Int J Radiat Oncol Biol Phys 2004;60:814-21.
33. Serkies K, Jassem J. Primary radiotherapy of stage IIA/B-IIIB cervical carcinoma. A comparison of continuous versus sequential regimens [Letter to the Editor]. Strahlenther Onkol 2005;181:54.
34. Sheu MH, Chang CY, Wang JH, et al. Preoperative staging of cervical carcinoma with MR imaging: reappraisal of diagnostic accuracy and pitfalls. Eur Radiol 2001;11:1828-33.
35. Strauss HG, Kuhnt G, Laban C, et al. Chemoradiation in cervical cancer with cisplatin and high-dose rate brachytherapy combined with external beam radiotherapy. Results of a phase-II study. Strahlenther Onkol 2002;178:378-85.
36. Stryker JA, Mortel R. Survival following extended field irradiation in carcinoma of cervix metastatic to para-aortic lymph nodes. Gynecol Oncol 2000;79:399-405.
37. Tačev T, Vacek A, Ptáčková B, et al. Hypoxic versus normoxic external-beam irradiation of cervical carcinoma combined with californium-252 neutron brachytherapy. Strahlenther Onkol 2005;181:273-84.
38. Tamella J, Bundy B, Ondusi K. Reassessment of pelvic lymph node debulking in advanced cervical cancer. Gynecol Oncol 2004;92:1014-5.
39. Varveris H, Kachris S, Mazonakis M, et al. Phase I/II trial of external irradiation plus medium-dose brachytherapy given concurrently to liposomal doxorubicin and cisplatin for advanced uterine cervix carcinoma. Strahlenther Onkol 2006;182:125-34.
40. Vergote I, Amant F, Berteloot P, et al. Laparoscopic lower para-aortic staging lymphadenectomy in stage IB2, II and III cervical cancer. Int J Gynecol Cancer 2002;12:22-6.
41. Whitney CW, Stehman FB. The abandoned radical hysterectomy: a Gynecologic Oncology Group study. Gynecol Oncol 2000;79:350-6.
42. Windschall A, Ott OJ, Sauer R, et al. Radiation therapy and simultaneous chemotherapy for recurrent cervical carcinoma. Strahlenther Onkol 2005;181:545-50.
43. Wright JD, Dehdashti F, Herzog TJ, et al. Preoperative lymph node staging of early-stage cervical carcinoma by [18F]-fluoro-2-deoxy-D-glucose-positron emission tomography. Cancer 2005;104:2484-91.
44. Zander J, Baltzer J, Lohe KJ, et al. Carcinoma of the cervix: an attempt to individualize treatment. Results of a 20-year cooperative study. Am J Obstet Gynecol 1981;139:752-9.